在乳腺癌中,SMARCC2沉默通过调节染色质可访问性来抑制瘤原性激活
Zhaoran Sun1, Zhongkun Wang2, Yirao Zhang1
1Jiangsu Key Laboratory of Brain Disease and Bioinformation, Xuzhou Medical University, Xuzhou, China.
Biochemical and biophysical research communications
|June 9, 2024
概括
作为SWI/SNF复合体的一个组成部分,SMARCC2令人惊地促进了乳腺癌的生长和干细胞特征. 它的耗尽通过降低Ras-PI3K通路的调节来抑制瘤,从而将SMARCC2确定为潜在的治疗标.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 染色体重塑 染色体重塑 的方法
背景情况:
- SWI/SNF染色体重塑复合体是基因转录至关重要的表观遗传调节剂.
- 这些复合物通常被认为是癌症中的瘤抑制剂.
- 与其他SWI/SNF子单位相比,对BAF核心组成部分SMARCC2的研究是有限的.
研究的目的:
- 研究SMARCC2在乳腺癌中的作用.
- 为了确定SMARCC2是否在乳腺癌中充当瘤抑制剂或瘤基因.
主要方法:
- 在体外和体内测试,包括细胞增殖,乳球形成和异种移植模型.
- 基因组分析,例如RNA-seq,ATAC-seq和ChIP.
- 对Ras-PI3K信号通路的研究.
主要成果:
- 沉默SMARCC2抑制了乳腺瘤的发生,这表明它起到了促进瘤的作用.
- 减少SMARCC2减少了癌症干细胞的特征.
- 沉默SMARCC2降低了Ras-PI3K通路的调节,这可能是通过直接调节PIK3CB等基因对增强器染色质可访问性的直接调节.
结论:
- 在乳腺癌中,SMARCC2表现出一种亲瘤的功能,与其他SWI/SNF子单元形成鲜明对比.
- SMARCC2在维持癌症干细胞特征方面发挥着作用.
- SMARCC2是乳腺癌治疗的潜在治疗点.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K


